A review on oxaliplatin-induced peripheral nerve damage.
about
Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice GuideReview of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatmentsLifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review.Membrane transporters as mediators of Cisplatin effects and side effects.Anticancer activity of methyl-substituted oxaliplatin analogs.Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations.Transient bilateral abducens neuropathy with post-tetanic facilitation and acute hypokalemia associated with oxaliplatin: a case reportComparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients.[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?RNA-seq identifies determinants of oxaliplatin sensitivity in colorectal cancer cell lines.Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats.Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging.Oxaliplatin-induced chronic peripheral neurotoxicity: a prospective analysis in patients with colorectal cancer.Oxaliplatin: a review in the era of molecularly targeted therapySpinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.Oxaliplatin neurotoxicity of sensory transduction in rat proprioceptorsCalcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?Neurotoxicity caused by the treatment with platinum analogues.Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.Cancer treatment-related neuropathic pain: proof of concept study with menthol--a TRPM8 agonist.Complex impairment of IA muscle proprioceptors following traumatic or neurotoxic injuryProlonged oxaliplatin exposure alters intracellular calcium signaling: a new mechanism to explain oxaliplatin-associated peripheral neuropathy.Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in ratsPeripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies.Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivityCombined Effects of Bee Venom Acupuncture and Morphine on Oxaliplatin-Induced Neuropathic Pain in Mice.Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancerAn animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathwaysSelf-management of oxaliplatin-related peripheral neuropathy in colorectal cancer survivorsPotential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies.Wen-Luo-Tong Prevents Glial Activation and Nociceptive Sensitization in a Rat Model of Oxaliplatin-Induced Neuropathic PainTreatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy.Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature.Targeting and delivery of platinum-based anticancer drugs.Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know.Polymeric biomaterials for the delivery of platinum-based anticancer drugs.
P2860
Q26749476-CC8451BB-31AA-4F50-87CC-716842A59D9DQ28082382-C32814CF-186F-471F-891B-5ED077EB661DQ30234847-C18C0F72-DAA0-40F0-974A-33C6A055E68AQ30446860-DF1A325E-4015-4AE9-94A5-4CFFD4FB0439Q30515979-853D7111-A81D-4DB6-9D00-87AC2C81165FQ33397057-2933A7BC-F0F3-4D85-B97F-02DF1E6E89F6Q33683346-D15823AE-54E3-44B4-878C-2060ADC7B920Q33711444-F70BE399-CBDB-42B4-B4CF-0EACD906F04AQ33770708-CEBBB177-5053-4498-9D60-73FA14631BE1Q33824948-5ABC45BF-E7E5-4708-81ED-2CA4F4CA8885Q34028959-63DF3E94-D466-4458-A08F-D370963A69C5Q34380468-A5DF6090-3FD5-4FA9-BF37-286E642CEC06Q34430049-91068E05-539F-49E4-A741-48EA3224219EQ34494728-DC9E09CF-C13A-4F3D-8E5B-CAABE4CAD1E0Q34541434-1D0E6045-E3B3-4C0A-89B4-6CD84E8763CFQ34765028-C6C8A2BF-697A-4A4A-B45B-45FF438F7E22Q35000576-2CA97DDA-BFD4-4486-A0C0-69968B619C0EQ35160434-085981FE-734D-41E9-B02E-72859BF8A9BCQ35642335-747DC686-8BBF-4053-92F2-9BDB5F828E3AQ35692169-05B8B3E6-E0B9-4BBA-B6B8-4C1B786BA237Q35740234-17A9A9B4-8D23-47D3-9CF8-BD9A55ABDC55Q35901628-75DA73AA-395B-47B9-B4AF-C666FBDAAD58Q35911716-C4D04126-761E-42FA-9DCC-995532390F9DQ36073448-6582680F-A190-4393-BCE0-A0FE7C494B75Q36254642-EBE491F1-7020-4800-916F-65923D61865EQ36344699-DF21AF35-8828-4F3A-A20E-2A31E05C8389Q36530731-620AD445-FE96-436D-9B70-4BF8F0E575DFQ36586687-3CFBFA32-B07E-4C40-9194-A8C45543DB48Q36638304-0CD7B244-2FDF-4319-A29C-B88233F1E751Q36651474-FA048521-73DF-4B27-AE4C-4408A008B0A3Q37107220-C5199728-BC70-4131-9204-808D9AF75CE3Q37155944-70C6FDF0-6485-4516-AED6-F41F79CACC05Q37168753-216B55ED-26DB-4017-906A-ACFA0B348551Q37239639-68D9DBD1-2ACB-4952-8292-62668D34A3EBQ37410573-9C6C02D2-DE51-4417-AE91-16A843FD4984Q37541146-04F33BFD-A169-47CC-BD1F-161BFC31E370Q37659699-7868E2EA-6BD2-44B7-8BF1-50090F8ADC21Q38050063-4CF7D873-7A8A-4B31-93C6-41856664A709Q38224422-52F99E8A-8793-48D3-B98A-480F4F937E85Q38556758-417E8A4C-DAB4-47C4-B291-2EB9539C79F6
P2860
A review on oxaliplatin-induced peripheral nerve damage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review on oxaliplatin-induced peripheral nerve damage.
@en
A review on oxaliplatin-induced peripheral nerve damage.
@nl
type
label
A review on oxaliplatin-induced peripheral nerve damage.
@en
A review on oxaliplatin-induced peripheral nerve damage.
@nl
prefLabel
A review on oxaliplatin-induced peripheral nerve damage.
@en
A review on oxaliplatin-induced peripheral nerve damage.
@nl
P2093
P1476
A review on oxaliplatin-induced peripheral nerve damage
@en
P2093
Andreas A Argyriou
Elisabeth Chroni
Panagiotis Polychronopoulos
P304
P356
10.1016/J.CTRV.2008.01.003
P577
2008-02-20T00:00:00Z